FFTY:ARCA-Innovator IBD 50 Fund

ETF | Mid-Cap Growth | NYSE Arca

Last Closing

USD 34.31

Change

+0.43 (+1.27)%

Market Cap

USD 0.07B

Volume

0.25M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in companies included in the IBD? 50 Index. The fund will generally hold all of the companies included in the IBD? 50 Index other than during periods when the fund is rebalanced due to changes in the constitution of the IBD? 50 Index. The fund, however, will not invest in the IBD? 50 Index companies in the same proportion as reflected in the index.

Inception Date: 08/04/2015

Primary Benchmark: IBD 50 Index USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.13%

Management Expense Ratio: 0.80 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
LFUS Littelfuse Inc 3.36 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-06-18 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Mer Price(Change) Market Cap
VOT Vanguard Mid-Cap Growth Index .. 0.07 %

+2.37 (+1.02%)

USD 24.16B
IWP iShares Russell Mid-Cap Growth.. 0.24 %

+0.99 (+0.88%)

USD 15.17B
IJK iShares S&P Mid-Cap 400 Growth.. 0.24 %

+1.12 (+1.24%)

USD 8.12B
MDYG SPDR® S&P 400 Mid Cap Growth .. 0.15 %

+1.07 (+1.24%)

USD 3.06B
XMMO Invesco S&P MidCap Momentum ET.. 0.39 %

+0.55 (+0.48%)

USD 1.60B
IVOG Vanguard S&P Mid-Cap 400 Growt.. 0.20 %

+1.31 (+1.17%)

USD 0.78B
RFG Invesco S&P MidCap 400® Pure .. 0.35 %

+0.43 (+0.85%)

USD 0.31B
IPO Renaissance IPO ETF 0.60 %

-0.04 (-0.08%)

USD 0.18B
ETHO Etho Climate Leadership U.S. E.. 0.45 %

+0.95 (+1.66%)

USD 0.18B
CWS AdvisorShares Focused Equity E.. 0.68 %

+0.73 (+1.17%)

USD 0.14B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 24.22% 75% C 85% B
Dividend Return N/A N/A N/A N/A F
Total Return 24.22% 70% C- 83% B
Trailing 12 Months  
Capital Gain -8.46% 28% F 34% F
Dividend Return N/A N/A N/A N/A F
Total Return -8.46% 22% F 30% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain 11.29% 94% A 84% B
Dividend Return 11.34% 83% B 80% B-
Total Return 0.05% 11% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 18.55% 11% F 38% F
Risk Adjusted Return 61.13% 39% F 67% D+
Market Capitalization 0.07B 60% D- 46% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.